The industrial application requirement for biotech inventions in light of recent EPO & UK case law: A plausible "hunting license"?
Aktivitet: Tale eller præsentation - typer › Foredrag og mundtlige bidrag
Timo Minssen - Foredragsholder
- JUR Forskningscenterområdet
- JUR Center for Informations- og innovationsret
This presentation will discuss the most recent developments relating to the “industrial application” requirement with a special emphasis on gene and protein-related inventions in Europe. In addition to providing a brief overview of the applicable legislative framework, this presentation will address relevant EPO practice and the UK Supreme Court’s seminal decision in HGS v Eli Lilly.
12 aug. 2013
Begivenhed (Kursus)
| Titel | Pharmaceutical Law & Policy- Hot topics shaping the future of the pharma industry |
|---|---|
| Forkortet titel | CSU 2013 |
| Dato | 12/08/2013 → 16/08/2013 |
| Afholdelsessted | Frederiksberg Campus |
| By | Copenhagen |
| Land/Område | Danmark |
Relaterede Publikationer (1)
- Udgivet
The industrial application requirement for biotech inventions in light of recent EPO & UK case law: A plausible "hunting license"?"
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
ID: 49702634